Mindera Platform Named MedTech’s “Best New Technology Solution for Dermatology"

The Mindera platform can help predict the appropriate biologic drug for a patient prior to therapeutic selection and treatment.

Mindera Corporation took home the "Best New Technology Solution for Dermatology" award at the fifth annual MedTech Breakthrough Awards program.

The Mindera platform uses a patch that takes minutes to extract biomarkers, allowing for minimally invasive, rapid and painless extraction of RNA from the skin using a dermal biomarker patch. 

Subsequent Next-Generation Sequencing of the extracted RNA allows Mindera scientists to take a genetic and transcriptomic snapshot of the skin at the exact moment of the test. 

This patient-specific data set is then analyzed by machine learning algorithms to ask sophisticated questions of the data, for example, predicting the appropriate biologic drug for a patient prior to therapeutic selection and treatment.

The ability to collect patient data at scale, combined with high precision molecular testing, results in a powerful platform with improved sensitivity and specificity, translating into huge cost savings for healthcare systems, particularly when applied to the prediction of response to hyper-expensive treatments. Biomarkers captured using the Mindera platform include DNA, RNA, protein, and small molecules; in particular, the role of RNA in chronic skin diseases is well characterized.

"Patients get the right biologic the first time and have improved outcomes while the payers save wasted dollars that were the result of being a non-responder to treatment. Precision medicine is an integrated approach to better patient outcomes," says George Mahaffey, CEO of Mindera, in a news release. "We're proud of our platform and equally proud to receive this recognition from MedTech Breakthrough with this 2021 MedTech Breakthrough Award win."

"Mindera's digital predictive skin analytics platform represents a significant dermatology breakthrough, allowing for a dramatic improvement in how patients are diagnosed and treated," adds James Johnson, managing director, MedTech Breakthrough. "This is taking MedTech to its highest level - being able to target treatment to each individual patient. Congratulations to Mindera for their for their success and innovation, taking home a well-deserved award win for 'Best New Technology Solution for Dermatology'."